COMMUNIQUÉS West-GlobeNewswire

SRx Health Solutions to Consider Allocating Up to 10% of Future Cash Flows and Cash Reserves to Bitcoin, Solana and Gold
01/05/2025
TAMPA, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that it will explore an initiative to [...]
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection
01/05/2025
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and [...]
Senti Bio Releases Virtual Investor “What This Means” Segment
01/05/2025
Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio discusses the positive data from lead program, SENTI-202, recently presented at the American Association for Cancer Research ( [...]
Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025
01/05/2025
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
01/05/2025
Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company "), an artificial intelligence ("AI")-powered medical technology company focused on transforming [...]
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
01/05/2025
John Woock joins as Chief Business Officer; Konstantinos Alataris, PhD, appointed to Board of Directors NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a pioneering brain– [...]
Eleos Advances Comprehensive Behavioral Health Product Capabilities
01/05/2025
The new Eleos Documentation experience brings industry-leading augmented intelligence tools to more behavioral health use cases, 150+ languages, and rural or offline care settings Eleos dives deeper into Spring product [...]
Resmed Acquires VirtuOx
01/05/2025
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD [...]
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
01/05/2025
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD data from the [...]
Promex Industries Expands Best-in-Class Capabilities, Installing Laser Depaneling and Advanced SPI Systems on Manufacturing Line
01/05/2025
New Capabilities Support Higher-Density Assemblies, Flex Substrates, and Emerging Chiplet Architectures with Precision and Scale SANTA CLARA, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Promex Industries, Inc. , a Silicon [...]
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure
01/05/2025
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
SPR Expands Access to the SPRINT® PNS System for Veterans with New Distribution Agreement with Veteran’s Health Medical Supply
01/05/2025
- National clinical review and contract offers an easier path to care for millions of Veterans - CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- SPR announced today that the SPRINT PNS System is now available on the [...]
RoomSync Partners with Counslr to Launch the Fall Pass to Improve Community Well-being and Increase Revenue
01/05/2025
Student Residents Across the US to Have 24/7/365 Access to Text-based Mental Health Support to Mitigate Heightened Periods of Stress NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading digital mental health [...]
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology
01/05/2025
Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody [...]
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
01/05/2025
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases [...]
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
01/05/2025
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will [...]
Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders
01/05/2025
New patent covers a treatment method for a broad spectrum of alcohol-related disorders, including additional conditions associated with alcohol use GLEN ALLEN, Va., May 01, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals [...]
Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit
01/05/2025
Carlsbad, CA, May 01, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel [...]
Extendicare Announces Agreement to Acquire Closing the Gap Healthcare Group
01/05/2025
MARKHAM, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“ Extendicare ” or the “ Company ”) (TSX: EXE) announced today that its wholly owned home health care subsidiary, ParaMed Inc. (“ ParaMed ” or the “ [...]

Pages